Efficacy and safety of triiodothyronine supplementation in patients with major depressive disorder treated with specific serotonin reuptake inhibitors-Reference-Cited by-同舟云学术

Efficacy and safety of triiodothyronine supplementation in patients with major depressive disorder treated with specific serotonin reuptake inhibitors

Published:2007-11-30 Issue:05 Volume:11 Page:
ISSN:1461-1457
Container-title:The International Journal of Neuropsychopharmacology
language:en
Short-container-title:Int. J. Neuropsychopharm.

Author:

Cooper-Kazaz Rena,Lerer Bernard

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology

Link

http://academic.oup.com/ijnp/article-pdf/11/5/685/2907356/11-5-685.pdf

Reference63 articles.

1. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and Continuation Treatment of Major Depressive Disorder

2. IMPROVEMENT IN MENTAL DEPRESSION WITH DECREASED THYROTROPIN RESPONSE AFTER ADMINISTRATION OF THYROTROPIN-RELEASING HORMONE

3. l-thyroxine augmentation of serotonergic antidepressants in female patients with refractory depression

4. Rapid Cycling Bipolar Affective Disorder

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of selective serotonin reuptake inhibitors on endocrine system (Review);Biomedical Reports;2024-07-05

2. Treatment-Resistant Depression in Older Adults;New England Journal of Medicine;2024-02-15

3. Medications for Depression: Monoamine Enhancers and Esketamine (Antidepressants);Tasman’s Psychiatry;2024

4. Prescription réfléchie pour les patients souffrant d’une dépression difficile à traiter;Canadian Family Physician;2023-11

5. Thoughtful prescribing for patients with difficult-to-treat depression;Canadian Family Physician;2023-11